Leadership Overview
SAMSUNG BIOLOGICS has 4 executives leading key functions including information technology, global marketing, financial operations, and cell culture engineering.
Focused on advancing global biopharmaceutical manufacturing, SAMSUNG BIOLOGICS delivers high-quality CDMO services while maintaining a commitment to innovation, operational excellence, and the rapid development of life-saving therapeutic products for international markets.
Focused on advancing global biopharmaceutical manufacturing, SAMSUNG BIOLOGICS delivers high-quality CDMO services while maintaining a commitment to innovation, operational excellence, and the rapid development of life-saving therapeutic products for international markets.
Leadership Roles at SAMSUNG BIOLOGICS
Seungho Ryu - Executive Vice President & Head Chief Financial Officer, The Business Support Center
Seungho Ryu, the Executive Vice President & Head Chief Financial Officer, The Business Support Center at SAMSUNG BIOLOGICS, manages the financial health and resource allocation for large-scale biopharmaceutical operations. Overseeing the Business Support Center, the Executive Vice President & Head Chief Financial Officer, The Business Support Center directs capital budgeting for facility expansion and advanced analytical testing equipment. This leadership role involves monitoring fiscal performance across the CDMO and Biopharmaceutical Development segments to ensure profitability. By optimizing cost structures for clinical manufacturing and biosimilar drug research, Ryu supports the overall financial stability of the organization. The Executive Vice President & Head Chief Financial Officer, The Business Support Center collaborates with other executives to evaluate investment risks associated with international market entry. Through rigorous financial oversight, Seungho Ryu maintains the fiscal discipline required to fund ongoing innovation in antibody-drug conjugates and other complex therapeutic development projects.
Jae Lee - Chief Information Officer
Jae Lee, the Chief Information Officer at SAMSUNG BIOLOGICS, directs the digital transformation of complex biopharmaceutical manufacturing processes. Overseeing the integration of advanced data analytics and secure cloud infrastructure, the Chief Information Officer ensures seamless connectivity across global production facilities. This leadership role involves architecting robust cybersecurity frameworks to protect proprietary cell line development data and clinical manufacturing records. By implementing automated systems for quality assurance and biosafety testing, Lee optimizes operational efficiency across the entire CDMO value chain. The Chief Information Officer collaborates with the Board to align technological investments with long-term growth objectives in the United States and Europe. Through the deployment of sophisticated enterprise resource planning tools, Lee enhances supply chain visibility and manufacturing precision. Ultimately, Jae Lee secures the digital foundation necessary for maintaining the competitive edge of the company in the international biopharmaceutical market.
James Choi - Executive Vice President & Head Chief Marketing Officer, Sales Support & Global Public Affairs
James Choi, the Executive Vice President & Head Chief Marketing Officer, Sales Support & Global Public Affairs at SAMSUNG BIOLOGICS, drives the commercial strategy for contract development and manufacturing services. Overseeing global market expansion, the Executive Vice President & Head Chief Marketing Officer, Sales Support & Global Public Affairs manages relationships with international pharmaceutical partners to secure long-term manufacturing contracts. This leadership role involves coordinating public affairs initiatives to strengthen the corporate brand across South Korea, Europe, and the United States. By aligning sales support functions with client needs for aseptic filling and lyophilization services, Choi ensures consistent revenue growth. The Executive Vice President & Head Chief Marketing Officer, Sales Support & Global Public Affairs works closely with the C-suite to communicate the value proposition of mammalian and mRNA product manufacturing capabilities. Through strategic market positioning, James Choi expands the reach of the company, ensuring sustained commercial success in the competitive global biopharmaceutical landscape.
Jiye Nam - Engineer- Chief Marketing Officer, Cell Culture
Jiye Nam, the Engineer- Chief Marketing Officer, Cell Culture at SAMSUNG BIOLOGICS, architects the technical marketing strategy for specialized cell line development and process optimization services. Overseeing the technical interface between engineering teams and potential clients, the Engineer- Chief Marketing Officer, Cell Culture translates complex scientific capabilities into actionable manufacturing solutions. This leadership role involves promoting the expertise of the company in mammalian cell culture to attract high-value biopharmaceutical partners. By highlighting the precision of discovery and process development services, Nam drives demand for the advanced manufacturing facilities. The Engineer- Chief Marketing Officer, Cell Culture works with the R&D department to ensure that marketing materials accurately reflect the latest breakthroughs in biosafety and analytical testing. Through technical leadership, Jiye Nam positions the company as a premier partner for complex drug development, directly influencing the acquisition of new clinical manufacturing projects across global markets.
Explore Leadership Teams in Manufacturing
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Company Leadership CK
KP

Emcure Pharmaceuticals Limited is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products and healthcare solutions. Headquartered in Pune, India, the organization operates as an international pharmaceutical enterprise with a strong presence in both domestic and global healthcare markets. The company focuses on delivering innovative and affordable medicines that address a wide spectrum of medical conditions and therapeutic needs across the healthcare sector. The organization is driven by a research-focused strategy that emphasizes innovation, scientific advancement, and the development of effective therapeutic solutions. Through its research and development capabilities, Emcure Pharmaceuticals works to discover and formulate medicines that address unmet medical needs and improve patient outcomes. The company’s research initiatives focus on areas such as complex generics, biosimilars, biologics, and specialized pharmaceutical formulations. These research efforts allow the organization to continuously introduce improved therapies and drug delivery systems designed to enhance treatment effectiveness and patient safety.
Company Leadership SM

NS
Hypera SA is a company that operates in the Pharmaceuticals industry. It employs 5000to9999 people and has 1Gto5G of revenue. The company is headquartered in Sao Paulo, Sao Paulo, Brazil.
Company Leadership AR
TR
LM
Founded in 1950 and headquartered in Hortolândia, Brazil, EMS Pharma is a domestic pharmaceutical company. They are a distributor of pharmaceuticals in Brazil.
Company Leadership OS
CM
RC